From Clinical Care Options, view this CME-certified video featuring expert perspectives on treatment of patients with myeloproliferative neoplasms
Expert answers to key questions on the current treatment of myeloproliferative neoplasms from a Clinical Care Options (CCO) symposium at ASH 2019
Data on venetoclax with or without azacitidine in patients with relapsed/refractory MDS from ASH 2019 as reported by Clinical Care Options (CCO)
From Clinical Care Options, download slides reviewing the optimal management of MPNs.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.